PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2014Cold Spring Harbor Perspectives in Medicine132 citationsOpen Access

Myocardial Tissue Engineering: In Vitro Models

GVGordana Vunjak‐NovakovicTEThomas EschenhagenCMChristine L. Mummery

Key Result

Engineered functional human myocardium mimics native heart tissue to enable physiological studies, drug screening for therapeutics, and safety pharmacology in vitro.

Structured PICO

P
Population
In vitro models of functional human myocardium
I
Intervention
Myocardial tissue engineering

Engineered human myocardium models provide a biologically faithful platform for drug screening, disease modeling, and safety pharmacology.

Limitations

  • Immaturity of hPSC-derived cardiac myocytes
  • Imperfection of cardiac tissue quality in 3D models
  • Difficulties to control culture conditions at a level required by good laboratory practice standards

Abstract

Modeling integrated human physiology in vitro is a formidable task not yet achieved with any of the existing cell/tissue systems. However, tissue engineering is becoming increasingly successful at authentic representation of the actual environmental milieu of tissue development, regeneration and disease progression, and in providing real-time insights into morphogenic events. Functional human tissue units engineered to combine biological fidelity with the high-throughput screening and real-time measurement of physiological responses are poised to transform drug screening and predictive modeling of disease. In this review, we focus on the in vitro engineering of functional human myocardium that mimics heart tissue for analysis of myocardial function, in the context of physiological studies, drug screening for therapeutics, and safety pharmacology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vunjak‐Novakovic et al. (2014) conducted a review in Myocardial tissue engineering. Engineered functional human myocardium mimics native heart tissue to enable physiological studies, drug screening for therapeutics, and safety pharmacology in vitro.

synapsesocial.com/papers/6a159ca35347fbb173a00b21https://doi.org/10.1101/cshperspect.a014076
Ask AI
Helpful
Bookmark
Share
View Full Paper